Moderate Exercise Reduces Inflammation at The Cellular Level, New Study Finds

Health & Lifestyle
267

Listen to article (english)

Translate to Spanish or other 102 languages!

A new study found that moderate exercise reduced inflammatory markers by altering gene expression in bone marrow cells. Image for illustration purposes
A new study found that moderate exercise reduced inflammatory markers by altering gene expression in bone marrow cells. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers investigated the effects of exercise on inflammation in mice. 
  • They found that regular moderate exercise reduces inflammatory markers in mice. 
  • This was due to epigenetic changes that affected the expression of genes responsible for the inflammatory responses of certain immune cells.
  • Further studies are needed to see if these findings translate to humans. 

Inflammation happens when the body’s immune system has a reaction. This could be to pathogens such as germs, foreign bodies, and anything else the immune system recognizes as foreign.

Follow the link below to read the full story on Medical News Today: 

https://www.medicalnewstoday.com/articles/moderate-exercise-reduces-inflammation-at-the-cellular-level

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
‘All-Inside’ Meniscal Repair Shows Good Long-Term Outcomes
Next article
Tips To Protect Babies from Harmful UV Rays

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -